Neil Dahiya

Zai Lab and Pfizer have entered into a strategic partnership focusing on the cutting-edge antibacterial medication Xacduro (sulbactam-durlobactam) for the market in mainland China. This initiative grants Pfizer’s partner entities exclusive rights to undertake various commercialization tasks for Xacduro within […]

The pharmaceutical firms Zenyaku Kogyo Co., Ltd. and Chugai Pharmaceutical Co., Ltd. have announced that Zenyaku has successfully secured regulatory authorization from Japan’s Ministry of Health, Labour and Welfare (MHLW) to expand the use of the anti-CD20 monoclonal antibody, Rituxan,

GSK plc has disclosed that Japan’s Ministry of Health, Labour and Welfare (MHLW) authorized a regulatory application to broaden the use of Arexvy, the recombinant adjuvanted RSV vaccine, to include adults between 50-59 who are at a higher risk of

The PCI (Pharmacy Council of India) has instructed pharmacists lacking an ABHA (Ayushman Bharat Health Account) number to obtain one as soon as possible and register their DIGI-PHARMed profile promptly with the ABHA number. This initiative aims to merge the

The central government is prioritizing the dual focus of the biotechnology sector towards embracing digital and green technologies. This approach aims to facilitate sustainable advancement and promote growth in a low-carbon economy. With biotechnology’s industrialization, there’s a surge of innovation,

The National Pharmaceutical Pricing Authority (NPPA) has updated the maximum allowable price for atorvastatin 10 mg, a medication used to lower cholesterol, following a directive from the Department of Pharmaceuticals’ review body. On October 4, the review panel approved a

The annual observance of the 63rd National Pharmacy Week in Tamil Nadu will see a joint coordination effort by the state’s branch of the Indian Pharmaceutical Association (TN IPA) and the esteemed Tamil Nadu Dr MGR Medical University. This year,

With a growing awareness around respiratory health issues, medical professionals emphasize the importance of early detection and lifestyle adjustments for those affected by chronic obstructive pulmonary disease (COPD). Dr. Ujjwal Parakh, a leading consultant in chest medicine at Sir Ganga

**Encouraging News from LAPIX Therapeutics** LAPIX Therapeutics, Inc., a company specializing in innovative oral treatments aimed at restoring immune system balance in autoimmune disorders, has announced promising initial findings from their phase 1 trial. This study was a randomized, double-blind,

Alloy Therapeutics Inc., a biotechnology company committed to making advanced drug discovery technologies more accessible, has entered into a strategic partnership and license agreement with Takeda Pharmaceutical Company Limited. This collaboration aims to enhance Takeda’s advanced iPSC-derived CAR-T cell platform